2024 annual financial data
Nektar Therapeutics 2024 Operating margin
Direct answer
Operating margin was -106.88%.
Operating income was -105,198,000 USD and net income was -118,961,000 USD.
Operating cash flow was -175,709,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 98,427,000 USD
- Operating income
- -105,198,000 USD
- Net income
- -118,961,000 USD
- Operating cash flow
- -175,709,000 USD